Kora Saúde Participações S.A.

BOVESPA:KRSA3 Voorraadrapport

Marktkapitalisatie: R$499.9m

Kora Saúde Participações Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Kora Saúde Participações heeft een totaal eigen vermogen van R$1.0B en een totale schuld van R$2.0B, wat de schuld-eigenvermogensverhouding op 198.7% brengt. De totale activa en totale passiva bedragen respectievelijk R$4.7B en R$3.7B. De EBIT Kora Saúde Participações is R$291.7M waardoor de rentedekking 0.9 is. Het heeft contanten en kortetermijnbeleggingen van R$173.1M.

Belangrijke informatie

198.7%

Verhouding schuld/eigen vermogen

R$2.04b

Schuld

Rente dekkingsratio0.9x
ContantR$173.10m
AandelenR$1.02b
Totaal verplichtingenR$3.70b
Totaal activaR$4.72b

Recente financiële gezondheidsupdates

Recent updates

Kora Saúde Participações S.A.'s (BVMF:KRSA3) Shares Climb 26% But Its Business Is Yet to Catch Up

Nov 06
Kora Saúde Participações S.A.'s (BVMF:KRSA3) Shares Climb 26% But Its Business Is Yet to Catch Up

Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Oct 28
Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Kora Saúde Participações S.A.'s (BVMF:KRSA3) Business And Shares Still Trailing The Industry

Sep 21
Kora Saúde Participações S.A.'s (BVMF:KRSA3) Business And Shares Still Trailing The Industry

Revenues Working Against Kora Saúde Participações S.A.'s (BVMF:KRSA3) Share Price Following 25% Dive

Jun 13
Revenues Working Against Kora Saúde Participações S.A.'s (BVMF:KRSA3) Share Price Following 25% Dive

Does Kora Saúde Participações (BVMF:KRSA3) Have A Healthy Balance Sheet?

May 23
Does Kora Saúde Participações (BVMF:KRSA3) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Kora Saúde Participações S.A.'s (BVMF:KRSA3) 26% Share Price Plunge

Apr 16
Why Investors Shouldn't Be Surprised By Kora Saúde Participações S.A.'s (BVMF:KRSA3) 26% Share Price Plunge

Little Excitement Around Kora Saúde Participações S.A.'s (BVMF:KRSA3) Revenues As Shares Take 25% Pounding

Feb 06
Little Excitement Around Kora Saúde Participações S.A.'s (BVMF:KRSA3) Revenues As Shares Take 25% Pounding

There Are Reasons To Feel Uneasy About Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital

Jan 17
There Are Reasons To Feel Uneasy About Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital

Kora Saúde Participações S.A. (BVMF:KRSA3) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Dec 05
Kora Saúde Participações S.A. (BVMF:KRSA3) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Should You Investigate Kora Saúde Participações S.A. (BVMF:KRSA3) At R$1.17?

Sep 07
Should You Investigate Kora Saúde Participações S.A. (BVMF:KRSA3) At R$1.17?

Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital Not Reflecting Well On The Business

Jul 24
Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital Not Reflecting Well On The Business

Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Jan 10
Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)

Kora Saúde Participações S.A. (BVMF:KRSA3) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Apr 04
Kora Saúde Participações S.A. (BVMF:KRSA3) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( R$1.3B ) KRSA3 } overtreffen de korte termijn passiva ( R$946.7M ).

Langlopende schulden: De kortetermijnactiva van KRSA3 ( R$1.3B ) dekken de langetermijnschulden ( R$2.8B ) niet.


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 181.8% ) KRSA3 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van KRSA3 is de afgelopen 5 jaar gedaald van 388.1% naar 198.7%.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Terwijl het verlieslatende KRSA3 voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.

Voorspelling contante baan: KRSA3 is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, zelfs bij een positieve vrije kasstroom die met 1.2 % per jaar krimpt.


Ontdek gezonde bedrijven